Kenosha, WI, United States of America

Kevin R Engh


 


Average Co-Inventor Count = 4.4

ph-index = 6

Forward Citations = 179(Granted Patents)


Location History:

  • Mundelein, IL (US) (2000 - 2002)
  • Kenosha, WI (US) (2003 - 2004)
  • Kenosha, IL (US) (2004)

Company Filing History:


Years Active: 2000-2004

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations by Kevin R Engh

Introduction

Kevin R Engh is a notable inventor based in Kenosha, Wisconsin. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release formulations. With a total of eight patents to his name, Engh's work has the potential to improve patient outcomes and reduce side effects associated with medication.

Latest Patents

One of Engh's latest patents is a controlled release formulation of divalproex sodium. This innovative oral polymeric formulation is designed for once-a-day administration of valproate compounds, such as divalproex sodium. It offers significant advantages over previous sustained release formulations by minimizing the variation between peak and trough plasma levels of valproate over a 24-hour dosing period. The formulation follows a zero-order release pattern, resulting in essentially flat plasma levels of valproate once steady-state levels are achieved. This advancement leads to a significantly lower incidence of side effects for patients consuming this formulation.

Career Highlights

Engh's career has been marked by his dedication to pharmaceutical innovation. His work at Abbott Laboratories Corporation has allowed him to focus on developing formulations that enhance the efficacy and safety of medications. His contributions have been recognized within the industry, and he continues to be a driving force in pharmaceutical research.

Collaborations

Engh has collaborated with notable colleagues, including Yihong Qiu and J Daniel Bollinger. These partnerships have fostered an environment of innovation and have contributed to the success of their projects.

Conclusion

Kevin R Engh's work in developing controlled release formulations has the potential to transform patient care in the pharmaceutical industry. His innovative approach and dedication to improving medication delivery systems highlight the importance of research and development in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…